BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12555225)

  • 1. Spontaneous regression of HIV-associated Hodgkin's disease.
    Parekh S; Koduri PR
    Am J Hematol; 2003 Feb; 72(2):153-4. PubMed ID: 12555225
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-associated primary bone marrow Hodgkin's lymphoma: a distinct entity?
    Shah BK; Subramaniam S; Peace D; Garcia C
    J Clin Oncol; 2010 Sep; 28(27):e459-60. PubMed ID: 20679601
    [No Abstract]   [Full Text] [Related]  

  • 3. Unusual sites of Hodgkin's lymphoma: CASE 1. HIV-associated Hodgkin's lymphoma of the stomach.
    Doweiko J; Dezube BJ; Pantanowitz L
    J Clin Oncol; 2004 Oct; 22(20):4227-8. PubMed ID: 15483034
    [No Abstract]   [Full Text] [Related]  

  • 4. Images in HIV/AIDS. Primary bone marrow presentation of Epstein-Barr virus-driven HIV-associated Hodgkin lymphoma.
    Salama ME; Perkins SL; Mariappan MR
    AIDS Read; 2007 Dec; 17(12):604-5. PubMed ID: 18178979
    [No Abstract]   [Full Text] [Related]  

  • 5. Human immunodeficiency virus-associated Hodgkin's disease.
    Spina M; Vaccher E; Nasti G; Tirelli U
    Semin Oncol; 2000 Aug; 27(4):480-8. PubMed ID: 10950375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary rectal Hodgkin's lymphoma: initial manifestation of HIV.
    Ranganathan V
    Am J Gastroenterol; 1996 Jan; 91(1):180-1. PubMed ID: 8561136
    [No Abstract]   [Full Text] [Related]  

  • 7. Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection.
    Hartmann P; Rehwald U; Salzberger B; Franzen C; Diehl V
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):401-10. PubMed ID: 15161439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
    Boué F; Gabarre J; Gisselbrecht C; Reynes J; Cheret A; Bonnet F; Billaud E; Raphael M; Lancar R; Costagliola D
    J Clin Oncol; 2006 Sep; 24(25):4123-8. PubMed ID: 16896005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's lymphoma in HIV: unusual presentations and improving outcomes.
    Siegel AB; Leonard JP
    Clin Adv Hematol Oncol; 2003 Oct; 1(10):616-7. PubMed ID: 16258459
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases.
    Thompson LD; Fisher SI; Chu WS; Nelson A; Abbondanzo SL
    Am J Clin Pathol; 2004 May; 121(5):727-38. PubMed ID: 15151213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extranodal rectal Hodgkin's lymphoma in an HIV-positive individual.
    Faridi A; Kalavar M; Aziz A; He Z; Steier W
    Clin Adv Hematol Oncol; 2003 Oct; 1(10):614-5. PubMed ID: 16258458
    [No Abstract]   [Full Text] [Related]  

  • 14. Profound neutropenia resulting from interaction between antiretroviral therapy and vinblastine in a patient with HIV-associated Hodgkin's disease.
    Makinson A; Martelli N; Peyrière H; Turriere C; Le Moing V; Reynes J
    Eur J Haematol; 2007 Apr; 78(4):358-60. PubMed ID: 17378895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS related malignant disease at regional institute of medical sciences.
    Gatphoh ED; Zamzachin G; Devi SB; Punyabati P
    Indian J Pathol Microbiol; 2001 Jan; 44(1):1-4. PubMed ID: 12561985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease.
    Hoffmann C; Chow KU; Wolf E; Faetkenheuer G; Stellbrink HJ; van Lunzen J; Jaeger H; Stoehr A; Plettenberg A; Wasmuth JC; Rockstroh J; Mosthaf F; Horst HA; Brodt HR
    Br J Haematol; 2004 May; 125(4):455-62. PubMed ID: 15142115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection with Hodgkin's disease: the virus makes a difference.
    McNeil C
    J Natl Cancer Inst; 1997 Jun; 89(11):754-5. PubMed ID: 9182968
    [No Abstract]   [Full Text] [Related]  

  • 19. AIDS-related lymphomas--potentially curable in the HAART era.
    Valencia ME
    AIDS Rev; 2006; 8(2):108-10. PubMed ID: 16848278
    [No Abstract]   [Full Text] [Related]  

  • 20. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
    Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.